For weeks, this ETF has been trading under heavy pressure, but the recent surge in volume suggests early accumulation and a potential shift in trend momentum.
Price is now approaching a major confluence zone:
Long-term descending resistance (red trendline)
Long-term ascending support (green trendline)
Horizontal structural level (yellow) around $48.64
This intersection typically produces large direction-defining moves, making the next few sessions extremely important.
📊 Technical Overview
[] Support Levels: $47.39 → $36.72 → $28.68
[] Resistance Levels: $48.64 → $56.00 → $64.00
[] Structure: Squeezing between descending macro trendline & rising support
[] Momentum: First strong bullish pivot in weeks; volume spike confirms renewed interest- Trend Bias: Bullish above $47.39, neutral-to-bearish below that
A clean breakout above $48.64 would confirm a trend reversal and open the path toward the $56–$64 range.
This ETF has historically produced aggressive expansions after breaking key compression points like this one.
📈 Market Context
When trendlines converge this tightly, algo-driven volatility frequently takes over, meaning:
Traders should watch for a surge in volume
A breakout candle often runs much farther than expected
Failed breakouts typically retrace to the lower trendline quickly
Macro conditions in related sectors (biotech, health innovation indices) have begun stabilizing, increasing the probability of bullish continuation.
💡 My Plan
[] Entry Zone: On breakout above $48.64 or retest of $47.39
[] Targets: $56.00 → $64.00
[] Stretch Target: $98.48 (long-term range expansion target)
[] Invalidation: Close below $36.72 = bearish continuation likely
Aggressive rotation plays like this often run fastest when the market least expects it — and
Do you think we blast through $48.64 or get rejected at the trendline?
Drop your thoughts ⬇️
I’ll post the breakout confirmation update once we get the move 📈
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
